Regulatory expertise QNova LifeSciences specializes in medical device commercialization across over 100 countries with a track record of navigating complex and evolving regulatory pathways. This positions them as a strategic partner for clients seeking faster, compliant market entry and reduced regulatory risk.

Proven speed to market The company claims to have reduced time to approval by over 600 days and achieved high success rates on NDA/ANDA/BLA submissions. This highlights a strong value proposition for sponsors aiming to accelerate launch timelines and capture early market share.

Device and drug success With extensive experience across 500+ commercialization projects including drugs, biologics, medical devices, and in vitro diagnostics, QNova demonstrates broad capabilities that can address end-to-end lifecycle needs for diverse client portfolios.

Quality and compliance focus A track record of 100% success on 510(k) submissions and CHMP marketing authorizations indicates a disciplined, quality-driven approach. This can be leveraged to target risk-averse clients seeking reliable regulatory outcomes.

Strategic partnerships Existing expertise as a Medical Device CRO with feasibility studies and SmartStudy design suggests opportunities to upsell services such as study design optimization, feasibility assessments, and post-approval support to optimize overall commercialization efficiency.